Literature DB >> 7480707

MR imaging of phagocytosis in experimental gliomas.

C Zimmer1, R Weissleder, K Poss, A Bogdanova, S C Wright, W S Enochs.   

Abstract

PURPOSE: To determine whether phagocytosis can be observed in vivo in glioma cells.
MATERIALS AND METHODS: Rat C6 glioma cells were studied in culture and after intracerebral implantation into 13 rats. Monocrystalline iron oxide nanoparticles (MION), a model marker of phagocytosis, was administered intravenously to tumor-bearing rats at 2-20 mg of iron per kilogram. Magnetic resonance (MR) imaging was performed at multiple time points.
RESULTS: Glioma cells in culture showed uptake of MION in amounts of up to 10 ng of iron per 10(6) cells, corresponding to approximately 50,000 particles per cell. Fluorescently labeled MION was found to be located primarily in tubular lysosomes. Intracerebral gliomas showed characteristic changes in signal intensity at MR imaging that peaked 12 hours after administration of MION and lasted up to 5 days; these changes corresponded to uptake and subsequent biodegradation of MION by tumor cells.
CONCLUSION: Phagocytosis of glioma cells can be detected in vivo with iron oxide-enhanced MR imaging, and this may permit accurate delineation of tumor margins.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7480707     DOI: 10.1148/radiology.197.2.7480707

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  38 in total

1.  Surgically induced intracranial contrast enhancement: potential source of diagnostic error in intraoperative MR imaging.

Authors:  M Knauth; N Aras; C R Wirtz; A Dörfler; T Engelhorn; K Sartor
Journal:  AJNR Am J Neuroradiol       Date:  1999-09       Impact factor: 3.825

2.  EGFRvIII antibody-conjugated iron oxide nanoparticles for magnetic resonance imaging-guided convection-enhanced delivery and targeted therapy of glioblastoma.

Authors:  Costas G Hadjipanayis; Revaz Machaidze; Milota Kaluzova; Liya Wang; Albert J Schuette; Hongwei Chen; Xinying Wu; Hui Mao
Journal:  Cancer Res       Date:  2010-07-20       Impact factor: 12.701

3.  Fluorescent nanoparticle uptake for brain tumor visualization.

Authors:  Rachel Tréhin; Jose-Luiz Figueiredo; Mikael J Pittet; Ralph Weissleder; Lee Josephson; Umar Mahmood
Journal:  Neoplasia       Date:  2006-04       Impact factor: 5.715

4.  Molecular MR Imaging Probes.

Authors:  Umar Mahmood; Lee Josephson
Journal:  Proc IEEE Inst Electr Electron Eng       Date:  2005-04       Impact factor: 10.961

Review 5.  Imaging macrophages with nanoparticles.

Authors:  Ralph Weissleder; Matthias Nahrendorf; Mikael J Pittet
Journal:  Nat Mater       Date:  2014-02       Impact factor: 43.841

6.  Cell tracking using (19)F magnetic resonance imaging: technical aspects and challenges towards clinical applications.

Authors:  Houshang Amiri; Mangala Srinivas; Andor Veltien; Mark J van Uden; I Jolanda M de Vries; Arend Heerschap
Journal:  Eur Radiol       Date:  2014-11-06       Impact factor: 5.315

7.  Monocrystalline iron oxide nanoparticles: possible solution to the problem of surgically induced intracranial contrast enhancement in intraoperative MR imaging.

Authors:  M Knauth; T Egelhof; S U Roth; C R Wirtz; K Sartor
Journal:  AJNR Am J Neuroradiol       Date:  2001-01       Impact factor: 3.825

Review 8.  On the origin of cancer metastasis.

Authors:  Thomas N Seyfried; Leanne C Huysentruyt
Journal:  Crit Rev Oncog       Date:  2013

9.  Functional response of tumor vasculature to PaCO2: determination of total and microvascular blood volume by MRI.

Authors:  Scott D Packard; Joseph B Mandeville; Tomotsugu Ichikawa; Keiro Ikeda; Kinya Terada; Stephanie Niloff; E Antonio Chiocca; Bruce R Rosen; John J A Marota
Journal:  Neoplasia       Date:  2003 Jul-Aug       Impact factor: 5.715

Review 10.  Perspectives on the mesenchymal origin of metastatic cancer.

Authors:  Leanne C Huysentruyt; Thomas N Seyfried
Journal:  Cancer Metastasis Rev       Date:  2010-12       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.